Qvella, a leading molecular diagnostics company, today announced it has raised US$20 million in Series A financing. The round of funding was co-led by RA Capital Management and Whitecap Venture Partners, and includes Hatteras Venture Partners and Sands Capital Ventures as syndicate partners.